Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damon Meyer

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nucleic Acids Research|April 18, 2023
Saccharomyces cerevisiae DNA polymerase IV overcomes Rad51 inhibition of DNA polymerase δ in Rad52-mediated direct-repeat recombinationPaula G Cerqueira, Damon Meyer, Lilin Zhang, et al.
Blood|November 26, 2002
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomasJohn M Pagel, Nathan Hedin, Krishnan Subbiah, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Rad51 determines pathway usage in post-replication repairDamon Meyer, Shannon J Ceballos, Steven Gore, et al.
Cancer Research|November 18, 2008
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivoDowdy Jackson, John Gooya, Shenlan Mao, et al.
Nature Communications|January 10, 2026
Rad51 determines pathway usage in post-replication repairDamon Meyer, Steven K Gore, Jie Liu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nucleic Acids Research|April 18, 2023
Saccharomyces cerevisiae DNA polymerase IV overcomes Rad51 inhibition of DNA polymerase δ in Rad52-mediated direct-repeat recombinationPaula G Cerqueira, Damon Meyer, Lilin Zhang, et al.
Blood|November 26, 2002
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomasJohn M Pagel, Nathan Hedin, Krishnan Subbiah, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Rad51 determines pathway usage in post-replication repairDamon Meyer, Shannon J Ceballos, Steven Gore, et al.
Cancer Research|November 18, 2008
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivoDowdy Jackson, John Gooya, Shenlan Mao, et al.
Nature Communications|January 10, 2026
Rad51 determines pathway usage in post-replication repairDamon Meyer, Steven K Gore, Jie Liu, et al.
Pageof 2